CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Prostate Cancer: A Unique and Common Cancer Affecting Men 

    Most cancers affect everyone, regardless of sex, race, age, and other factors. Prostate cancer, however, only affects…
    October 2, 2023| Max Mallet
  • 2021 William B. Coley Award Recipients Drs. Katalin Karikó and Drew Weissman Receive the 2023 Nobel Prize in Physiology or Medicine 

    On October 2 the Nobel Assembly at Karolinska Institute in Stockholm, Sweden, announced that the 2023 Nobel…
    October 2, 2023| Max Mallet
  • CRI Received a 100% ‘Four-Star Charity’ Rating – Here’s Why That Matters 

    When people seek out nonprofits with missions that align with their values, it can be initially challenging…
    September 18, 2023| Max Mallet
  • How CRI-Funded Scientists are Reducing and Guarding Against Childhood Cancers 

    A cancer diagnosis is always extremely difficult news for a patient and their family. It can be…
    September 15, 2023| Max Mallet
  • Drs. Carl June and Michel Sadelain to Receive 2024 Breakthrough Prize in Life Sciences

    CRI Scientific Advisory Council member Carl June, MD (University of Pennsylvania) and CRI Clinical Accelerator Advisor Michel…
    September 14, 2023| Max Mallet
  • Cancer Cabinet Declares Updates to President Biden’s Cancer Moonshot Initiative 

    U.S. President Joe Biden’s administration is following through on last year’s commitment to reignite the White House…
    September 13, 2023| Max Mallet
  • Dr. Jill O’Donnell-Tormey on the State of Cancer Immunotherapy and the Contributions CRI Continues to Make to the Field 

    iFrame is not supported! Recently, the Cancer Research Institute’s (CRI) CEO and Director of Scientific Affairs Jill…
    September 12, 2023| CRI Staff
  • Join #TeamCRI and Plan Your Own Tailgate for a Purpose

    The Cancer Research Institute (CRI) now has a new way to create a world immune to cancer,…
    August 30, 2023| CRI Staff
  • CRI’s Dr. Jill O’Donnell-Tormey Explains Five Things You Need to Know About Cancer Vaccines

    Vaccines had been effective at preventing viral and bacterial-borne viruses for two hundred years before the first…
    August 28, 2023| CRI Staff
Previous Page
1 … 13 14 15 16 17 … 91
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute